Hot topics in the prevention of respiratory syncytial virus disease

Expert Review of Vaccines

Volumn 10, Issue 3, 2011, Pages 291-293

  Habibi, Maximillian S ^a   Patel, Sanjay ^b   Openshaw, Peter ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LIVE VACCINE; MDT 637; MEDI 534; NB ALX 0171; NUCLEOLIN; PALIVIZUMAB; PEV 4; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; SENDAI VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANTIVIRAL THERAPY; BINDING AFFINITY; CONFERENCE PAPER; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH2 CELL; VIRUS LOAD;

AGED; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TREATMENT OUTCOME;

EID: 79953242766     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.13     Document Type: Conference Paper

References (0)